Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Cora Sternberg Robert Motzer Frede Donskov Toni K Choueiri |
| Publication date | June 5, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |